Mironid® Limited
Announced 08 Aug 2026$46.0M · Series B · Hospitals and Health Care · United Kingdom
Mironid Limited is an innovative new drug discovery company that develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins.
“🇬🇧 Last week was another big week for UK innovation - £368.5m deployed across the top 10 rounds (up 43% week-on-week), with AI showing up everywhere from cybersecurity to steel manufacturing. Here's the rundown:🛡️ Cambridge Aerospace (£222m Series C) Autonomous air defence systems. Backed by DFJ Growth, Lux Capital and Accel.”
14 more sources tracked. Read the full press release and reporter coverage.
Sign up to read →Investors: Scottish National Investment Bank, Roche Venture Fund.